InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001156039-22-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-03 2022-03-01+ ELV Kendrick Charles Morgan JR EVP, Pres, Commercial F - Tax $452.94 -914 10.7K -8% -$414.0K
DM 2022-03-03 2022-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +3,969 12.6K +46% $0
D 2022-03-03 2022-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +7,729 7,729 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-02 F D 110 $463.49 14,529 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2022-03-01 A A 2,031 $0.00 14,639 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2022.
3 Common Common Stock 2022-03-01 A A 1,938 $0.00 12,608 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 646 shares each on 3/1/2023, 3/1/2024 and 3/1/2025.
4 Common Common Stock 2022-03-01 F D 804 $451.50 10,670 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
5 Derivative Employee Stock Option (Right to Buy) 2022-03-01 A A 7,729 $0.00 7,729 D $451.50 · — to 2032-03-01 7,729 Common Stock (F4) The option represents a right to purchase a total of 7,729 shares, and is exercisable in three annual installments, with two installments of 2,576 shares each and one installment of 2,577 shares, beginning on 3/1/2023, which is the one-year anniversary of the option grant date.